HEMGENIX

Live / Registered — Registered (as of 15 Sept 2020)

What this means for you

Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 declaration of use was filed 14 Sept 2026 and is awaiting the USPTO's acceptance).

Record

Serial number
88782819
Registration number
6151564
Mark type
Word mark
Filed
03 Feb 2020
Published for opposition
30 Jun 2020
Registered
15 Sept 2020
Next maintenance filing
§8 declaration of use, filed 14 Sept 2026 — awaiting the USPTO's acceptance
Attorney of record
Scott D. Woldow

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations and vaccines for use in gene therapy and cell therapy; biological preparations for use in medical and clinical gene therapy and cell therapy for the treatment of hemophilia; clinical medical reagents for use in gene therapy, gene diagnosis and gene testing

Owner

Prosecution history

  • 14 Sept 2026 — TEAS SECTION 8 RECEIVED
  • 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 12 Aug 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 12 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 12 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 12 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 12 Aug 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 20 Jul 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 20 Jul 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 20 Jul 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 08 Jun 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
  • 30 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 30 Jun 2020 — PUBLISHED FOR OPPOSITION
  • 10 Jun 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

View this trademark record on Rightsy